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Abstract
The interaction of intermediate filaments (IFs) with the cell-cell adhesion complexes desmo-
somes is crucial for cytoskeletal organization and cell resilience in the epidermis and heart.
The intracellular desmosomal protein desmoplakin anchors IFs to the cell adhesion com-
plexes predominantly via its four last carboxy-terminal domains (C-terminus). However, it
remains unclear why the C-terminus of desmoplakin interacts with different IF types or if
there are different binding affinities for each type of IFs that may influence the stability of
cell-specific adhesion complexes. By yeast three-hybrid and fluorescence binding assays,
we found that the coiled-coil 1 of the conserved central rod domain of the heterodimeric cyto-
keratins (Ks) 5 and 14 (K5/K14) was required for their interaction with the C-terminus of des-
moplakin, while their unique amino head- and C-tail domains were dispensable. Similar
findings were obtained in vitro with K1/K10, and the type III IF proteins desmin and vimentin.
Binding assays testing the C-terminus of desmoplakin with assembled K5/K14 and desmin
IFs yielded an apparent affinity in the nM range. Our findings reveal that the same con-
served domain of IF proteins binds to the C-terminus of desmoplakin, which may help
explain the previously reported broad binding IF-specificity to desmoplakin. Our data sug-
gest that desmoplakin high-affinity binding to diverse IF proteins ensures robust linkages of
IF cytoskeleton and desmosomes that maintain the structural integrity of cellular adhesion
complexes. In summary, our results give new insights into the molecular basis of the IF-des-
mosome association.
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Introduction
Desmoplakin is a large desmosomal protein, member of the plakin family of cytolinkers. As an
essential component of multiprotein desmosome adhesion complexes, desmoplakin partici-
pates in cell-cell adhesion and serves as anchorage sites for intermediate filaments (IFs). Des-
mosomes are found in all epithelia and some non-epithelial tissues, such as cardiac muscle and
meninges [1, 2]. The amino (N)-terminal sequence and the plakin domain of desmoplakin
interact with the desmosomal proteins, plakophilin and plakoglobin that associate with the
transmembrane cadherins, desmogleins and desmocollins [3, 4], while the central region of
desmoplakin forms a parallel coiled-coil dimer [5]. The carboxy (C)-terminal tail of desmopla-
kin contains three plakin repeat domains (PRDs A, B, and C), a 103 amino acids linker
(located after the PRD B), and a carboxyl extremity (E) containing Gly-Ser-Arg (GSR) repeats
(S1 Fig) [6]. Previous studies demonstrated that the four C-terminal domains (C-terminus) of
desmoplakin are required for its interaction with IFs [7–9]. A similar structural requirement
has been observed for the binding of two other plakins to IFs, plectin and the epithelial isoform
of bullous pemphigoid antigen 1 (BPAG1e) (S1 Fig) [8, 10, 11]. It is known that desmoplakin
anchors different types of IFs to desmosomes, including cytokeratins (Ks) in epithelia, desmin
in cardiomyocytes and vimentin in arachnoidal meninges and follicular dendritic cells [7, 12–
14]. Phosphorylation of the GSR repeats in the C-extremity of desmoplakin and plectin
dynamically regulates the interaction of both proteins with IFs (S1 Fig) [15, 16].
Mutations in the desmoplakin gene (DSP) have been associated with human disorders
involving tissues exposed to mechanical stress [6, 17]. DSP variants often cause cutaneous and
cardiac diseases, such as palmoplantar keratoderma, skin fragility-woolly hair syndrome,
dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Intriguingly, compound heterozygous or homozygous recessive mutations in the DSP gene
that result in severe truncation of the C-terminus of desmoplakin cause severe skin blistering
leading to early death [17]. The critical role of the interaction of desmoplakin with IFs is
emphasized by the fact that mutations in either IF or DSP genes in human or the knockdown
of these genes in mouse models are associated with similar skin or muscle phenotypes [17–19].
Moreover, Ks or desmin knockdown in the epidermis or the heart, respectively, results in mis-
localization of desmoplakin [20, 21].
The IF cytoskeletal network imparts resilience to cells and tissues that experience mechani-
cal stress [22, 23]. IF genes are numerous (> 70) and show a broad expression pattern in many
cell types. IF proteins display a central α-helical domain of ~310 amino acids (required for
dimerization), flanked by globular N- and C-terminal head and tail domains of variable size
[24]. The epithelial type I Ks form heterodimeric proteins with their type II partners. Ks are
differentially expressed in epithelial cells depending on the specific developmental and differ-
entiation stage of a cell. Vimentin and desmin belong to the type III IF proteins, which also
include peripherin and glial fibrillary acidic protein. Notably, the type III IF proteins form
both homopolymers and heteropolymers with other type III, IV or VI IF proteins [21].
The assembly process of IFs is initiated by the parallel dimerization of the rod domain and
progresses by antiparallel lateral association of the coiled-coils into tetramers that interact with
each other via their head domain to form unit length filaments (ULFs). These ULFs subse-
quently anneal longitudinally and compress to form mature 11 nm-wide IFs [24]. The con-
served extremities of the central rod domain are essential for IF assembly, since even subtle
amino acid substitutions have devastating effects on IF formation [25, 26]. It is well established
that phosphorylation cascades regulate the assembly state of IF networks thereby controlling
cell plasticity, cell migration and cell division [27, 28].
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Despite the key role of desmoplakin in mediating the anchorage of IFs to desmosomes, the
mode of interaction of desmoplakin with IFs is still unclear. Previous studies showed that des-
moplakin specifically interacts with the head domain of monomeric type II epidermal Ks (K1,
K2, K5, and K6) but not with that of K8 [12]. Both K8 and K18 were necessary to observe an
interaction with the desmoplakin tail in yeast two- or three-hybrid (Y2/3H) system [29]. In
contrast, we found that desmoplakin preferentially interacts with heterodimers of both epider-
mal and simple epithelial Ks, independently of their head domain [8, 30]. Thus, this study
aims to identify the desmoplakin binding site(s) on IF proteins because this information is crit-
ical for understanding the association of IFs with desmoplakin and other plakins and could
shed insight into the molecular basis for a number of human disorders affecting the structural
integrity of desmosomes. In this study, we have characterized the binding site(s) of the C-ter-
minus of desmoplakin on IF proteins and estimated its apparent affinity for assembled IFs.
Materials and methods
Cell culture and transfection
Human epithelial kidney (HEK) 293T cells [31] were cultured in high glucose Dulbecco’s
Modified Eagle Medium (Thermo Fischer Scientific), supplemented with 10% fetal calf serum
(Sigma-Aldrich), 100 U/mL penicillin and 100 μg/mL streptomycin (Sigma-Aldrich). They
were transfected with the calcium phosphate method [32].
Cloning of cDNA constructs
Plasmids encoding enhanced green fluorescent protein (EGFP) and GAL4-DNA-binding
domain (BD) fused to the C-terminus of desmoplakin (DSP C-terminus) (desmoplakin amino
acid 2194 to 2871, GenBank accession No: NP_004406), with the amino acid substitution
S2849G to prevent inhibitory phosphorylation, were previously described [8]. Human vimen-
tin cDNA cloned in pDS5 was received from H. Herrmann (Heidelberg, Germany). cDNAs
encoding full-length or truncated IF proteins were cloned into pAS2.1, pACT2 (Takara Bio
Europe) or pACT2-URA [8] for Y2/3H assays, and into pET15b or pET23 (Merck) for expres-
sion of recombinant proteins in Escherichia coli (S1 Table) [8, 9, 11, 30, 33]. Cloning of mouse
K1-coil 1 (C1), mouse K10-C1, human K10-coil 2 to tail (C2-T), human vimentin-rod, -C1,
-C2 and human desmin-rod, -C1 and -C2 into pET15b introduced an H6-tag at their N-termi-
nus. Plasmids were generated by restriction enzyme-based cloning procedures with or without
PCR amplifications. Correctness of PCR-amplified constructs was verified by sequencing.
Protein sequence alignment
The following IF Genbank protein sequences were aligned with the MAFFT algorithm (ver-
sion 7.215) [34]; type I Ks: K9, NP_000217; K10, NP_000412; K12, NP_000214; K13,
NP_705694; K14, NP_000517; K15, NP_002266; K16, NP_005548; K17, NP_000413; K18,
NP_002267; K19, NP_002267; K20, NP_061883; K23, NP_056330; K24, NP_061889; K25,
NP_853512; K26, NP_853517; K27, NP_853515; K28, NP_853513; K71, NP_258259; K72,
NP_542785; K73, NP_778238; K74, NP_778223; K75, NP_004684; K76, NP_056932; K77,
NP_778253; K78, NP_775487; K79, NP_787028; K80, NP_872313; type II Ks: K1, NP_006112;
K2, NP_000414; K3, NP_476429; K4, NP_002263; K5, NP_000415; K6A, NP_005545; K6B,
NP_005546; K6C, NP_775109; K7, NP_005547; K8, NP_002264; Type III IF proteins: desmin,
NP_001918; vimentin, NP_003371.
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Polyacrylamide gel electrophoresis and western blotting
Polyacrylamide gel electrophoresis in presence of sodium dodecyl sulfate (SDS-PAGE) and
western blotting (WB) were performed as previously described [8]. Protein concentration was
measured with the Bradford protein assay (Bio-Rad) using bovine serum albumin (BSA) (frac-
tion V, AppliChem) as standard and absorbance at 280 nm for purified recombinant proteins.
Yeast two- and three-hybrid assays
These experiments were performed as previously described [35]. For each pair of Ks or frag-
ments of Ks tested in Y3H, their ability to interact with each other (hetero-dimerization) was
verified in Y2H assays with type I and II Ks cloned in pACT2 and pAS2.1, respectively. Growth
or no growth on both selection media (without histidine or without adenine) was carefully
recorded.
Expression and purification of recombinant IF proteins
K5. Chemicals were from Sigma-Aldrich if not otherwise stated. For K5, 10 mL of Luria-
Bertani (LB) medium, supplemented with 0.1% glucose, ampicillin 100 μg/mL and chloram-
phenicol 34 μg/mL (Amp/Cam), was inoculated with a single colony of E. coli Rosetta pLysS
(Merck), transformed with the plasmid pET23-K5, and incubated at 30˚C overnight (ON).
The next day, 9 mL of pre-culture was added to 900 mL of LB Amp/Cam + 0.1% glucose and
incubated at 37˚C until the optical density at 600 nm (OD600nm) reaches 0.6. The culture was
cooled down in a water bath to room temperature. Expression of K5 was induced by the addi-
tion of 0.1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and the culture was further
incubated at 22˚C ON. The next day, the culture was centrifuged at 3000 × g at 4˚C for 15 min.
From the bacterial pellet (4.2 g), inclusion bodies (IBs) were prepared as previously described
[11]. IBs were dissolved in the solubilization buffer, 20 mM Bis-Tris-propane, pH 9.0, 6 M
urea, 2 mM dithiothreitol (DTT), 100 μM phenylmethylsulfonyl fluoride (PMSF), 10 mL/g wet
bacterial pellet. Dissolved IBs were centrifuged at 20,000 × g at 4˚C for 30 min, dialyzed against
the cation exchanger column buffer, 20 mM sodium phosphate, pH 6.5, 6 M urea, 2 mM DTT,
100 μM PMSF, at 4˚C ON and centrifuged at 20,000 × g at 4˚C for 30 min. The supernatant
was filtrated through the filter unit Millex GV, 0.22 μm (Merck), and loaded, 20–30 mg total
protein/run, onto the cation exchanger column HiTrap SP Sepharose FF 1 mL (GE Healthcare
Life Sciences). K5 was eluted with a linear gradient over 30 mL from 0 to 0.375 M NaCl in the
cation exchanger column buffer. Pooled fractions were loaded ( 0.5 mL/run) on the column
Superdex 200 10/300 GL (GE Healthcare Life Sciences) equilibrated with 25 mM Tris-HCl, pH
8.0, 6 M urea, 0.3 M NaCl, 2 mM DTT, 100 μM PMSF. Fractions containing pure K5 were
pooled and stored at -80˚C (S2 Fig).
K14. For K14, 10 mL of LB Amp/Cam + 0.1% glucose, was inoculated with a single colony
of E. coli Rosetta (Merck), transformed with the plasmid pET23-K14, and incubated at 30˚C
ON. The next day, 9 mL pre-culture was added to 900 mL LB Amp/Cam + 0.1% glucose and
incubated 6 h at 37˚C (induction of K14 expression with IPTG was dispensable). The culture
was centrifuged at 3000 × g at 4˚C for 15 min. IBs were prepared from bacterial pellet (4.8 g),
solubilized and centrifuged as for K5. To the IB solution, 1 M HCl was added dropwise under
agitation to decrease the pH from 9.0 to 6.5. The solution was centrifuged at 20,000 × g at 4˚C
for 30 min. The supernatant was filtrated through the filter unit Millex GV, 0.22 μm, and
loaded onto the anion exchanger column UNO Q1 (Bio-Rad). K14 was eluted with a gradient
over 20 mL from 0 to 0.5 M NaCl in the anion exchanger column buffer, 20 mM Bis-Tris-pro-
pane, pH 6.5, 6 M urea, 2 mM DTT, 100 μM PMSF. Pooled samples were gel-filtrated as for
K5 (S2 Fig).
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K1, K8, K10, K18 and H6-tagged K fragments. K8 and K18 as well as K1, H6-K10 and
H6-tagged K fragments were expressed and purified as previously described [30]. H6-K10 was
further gel-filtrated in the same conditions as for K5 (S2 Fig).
Vimentin and desmin. Vimentin was purified following a published protocol [36]. LB
Amp/Cam + 0.1% glucose, 15 mL, was inoculated with a colony of E. coli Rosetta (DE3), trans-
formed with the plasmid pDS5-vimentin, and incubated at 30˚C ON. To 1.3 L LB Amp/Cam
+ 0.1% glucose, 13 mL of pre-culture was added and incubated at 37˚C until OD600nm = 0.6.
Vimentin expression was induced with 0.1 mM IPTG at 37˚C for 5 h. IBs were prepared from
bacterial pellet (10.5 g) as for K5. They were dissolved in 50 mL of the anion exchanger column
buffer, 5 mM Tris-HCl, pH 7.5, 8 M urea, 1 mM DTT, 100 μM PMSF, 1 mM EDTA, and 0.1
mM EGTA, and centrifuged at 20,000 × g at 4˚C for 30 min. Supernatant was filtrated through
the filter unit, Millex GV, 0.22 μm, and loaded onto the anion exchanger column HiTrap
DEAE 1 mL (GE Healthcare Life Sciences), 30 to 40 mg protein/run. Vimentin was eluted with
a linear gradient from 0 to 0.3 M KCl in the anion exchanger column buffer. Pooled fractions
were dialyzed against the previous anion exchanger column buffer and loaded, 15 mg protein/
run, onto the cation exchanger column HiTrap CM Sepharose, 1 mL (GE Healthcare Life Sci-
ences), equilibrated with the anion exchanger column buffer. Vimentin was eluted with a lin-
ear gradient over 20 mL from 0 to 0.3 M KCl in the anion exchanger column buffer. Pooled
samples were gel filtrated as for K5. Pure samples were supplemented with 10 mM methyl
ammonium chloride and stored at -80˚C. Similarly, desmin was purified following a published
protocol [37].
Vimentin-rod, -coil 1, -coil 2, desmin-rod, -coil 1 and -coil 2 were expressed in E. coli BL21
(DE3) as for vimentin. After centrifugation of the cultures at 3000 × g at 4˚C for 15 min, bacte-
rial pellets were directly solubilized in SDS-sample buffer, 1/10 of OD600nm × culture volume
(mL).
SUMO. For H6-small ubiquitin-related modifier (SUMO), LB Amp/Cam + 0.1% glucose
(10 mL) was inoculated with E. coli Rosetta transformed with pET-SUMO (Thermo Fischer
Scientific) and incubated at 37˚C ON. A 4 mL-fraction of the preculture was added to 400 mL
LB Amp/Cam + 0.1% glucose that was incubated at 37˚C until OD600nm = 0.6. Expression of
SUMO was induced by the addition of 0.1 mM IPTG. The culture was further incubated at
37˚C for 2.5 h and centrifuged at 3000 × g for 15 min at 4˚C. The pellet was resuspended in 10
mL of lysis buffer 20 mM sodium phosphate, pH 7.4, 0.5 M NaCl, 20 mM imidazole, 1/100
protease inhibitor cocktail set III (Calbiochem). The bacteria in suspension were lysed with
several 30 s-long sonication pulses using the apparatus Labsonic 2000 (Braun). Lysates were
centrifuged at 20,000 × g at 4˚C. The supernatant was filtrated through the filter Millex GV,
0.22 uM, and loaded onto the column HisTrap 1 mL (GE Healthcare). H6-SUMO was eluted
with the lysis buffer supplemented with 0.5 M imidazole, dialyzed against PBS, flash frozen in
liquid nitrogen and kept at -80˚C.
FluoBACE interaction assays
Spotting conditions for dot blots. IF proteins were spotted in the following buffers: K5/
K14 and BSA in 25 mM Tris–HCl, pH 7.4, 2 mM DTT, 8 M urea; K1/K10 in 25 mM Tris–HCl,
pH 7.4, 2 mM DTT, 2 M urea; K8/K18 in 10 mM Tris–HCl, pH 8.5, 2 mM DTT, 6 M urea;
vimentin in 5 mM Tris-HCl, pH 8.5, 1 mM DTT, 6 M urea, 1 mM EDTA, 0.1 mM EGTA; des-
min in 5 mM Tris-HCl, pH 8.5, 1 mM DTT, 4 M urea, 1 mM EDTA, 0.1 mM EGTA. Frag-
ments of K5/K14 and K1/K10 were spotted in the same conditions as full-length proteins [38–
41]. When Ks, full-length or fragment proteins, were mixed, they were considered as dimeric
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entities to calculate the amount of proteins to be spotted to have the same number of moles as
the individual monomeric proteins.
Interaction of K5 with K14-C2-T in spotting conditions used for dot blots. Purified K5
and H6-K14-C2-T were dialyzed against 25 mM Tris–HCl, 2 mM DTT, 8 M urea, pH 7.4 and
either loaded separately (6 nmol in 0.25 mL) or after being stoichiometrically mixed onto the
column Superdex 200 10/300 GL equilibrated in the same buffer. Eluted fractions were ana-
lyzed by SDS-PAGE. Well separated individual elution peaks (retention time of K5 was higher
than that of H6-K14-C2-T) merged into an early elution peak (retention time shorter than that
of H6-K14-C2-T) when both proteins were mixed together before the run.
Fluorescence overlay assays. Dot blot overlay assays were done as previously described
[11, 30]. For overlay of WBs, prepared membranes were stained with Ponceau-S, photo-
graphed with a digital camera (FusionPulse TS, Vilber Lourmat), washed several times in PBS,
blocked in PBS supplemented with 5% skim milk for 30 min at 4˚C, incubated with the soluble
fraction of HEK 293T cells expressing EGFP or EGFP-tagged proteins for 1 h at 4˚C, washed
3 × with PBS for 5 min at 4˚C and scanned for fluorescence with a Typhoon 9400 (GE Health-
care Life Sciences). Fluorescence and Ponceau-S signals were quantified with ImageQuant (GE
Healthcare Life Siences) and Image Studio (Li-COR), respectively. Results were plotted with
GraphPad Prism 7 (GraphPad Software, Inc.) and statistically analyzed using the one-way
ANOVA test, no matching-pairing, assumed Gaussian distribution, followed by the Tukey
multiple comparison test (ANOVA-Tukey).
Assembly of IFs from recombinant proteins. K5/K14 filaments were assembled as previ-
ously described [42]. Pure K5 and K14 were mixed at a 1.1:1 molar ratio, dialyzed against the
anion exchanger column buffer, 50 mM Tris-HCl, pH 8.0, 8 M urea, 2 mM DTT, 100 μM
PMSF, and loaded onto the anion exchanger UNO Q1 column, 1 mL. Elution was performed
with a gradient over 25 mL from 0 to 0.25 M NaCl in the anion exchanger column buffer (het-
erodimeric K5/K14 elutes last). K5/K14 heterodimers, 0.5 mg/mL, were dialyzed against 0.7
mM sodium phosphate, pH 7.5 (mixture of mono- and di-basic sodium phosphate, 0.7 mM
each, to reach the correct pH), 1 mM DTT. Protein concentration was re-measured after dialy-
sis. IF assembly was induced by the addition under agitation of 1/5 of volume of 0.7 mM
sodium phosphate, 120 mM KCl, pH 7.5 (20 mM KCl final) and incubation at 37˚C for 30
min. Formation of insoluble filaments was verified by centrifugation of aliquots (30 μL, 25 μg/
mL) at 20,000 × g at 4˚C for 30 min and analysis of proteins in the pellet and supernatant by
SDS-PAGE. K5/K14 was 90% insoluble.
Desmin, 0.6 mg/mL, was dialyzed against 2 mM sodium phosphate pH 7.5 (mixture of
mono- and di-basic sodium phosphate, 2 mM each, to reach the correct pH). After dialysis,
the concentration of desmin was determined. IF assembly was induced by the addition under
agitation of one volume (1:1) of 2 mM sodium phosphate pH 7.5, 200 mM KCl (100 mM KCl
final) [43] and incubation at 22˚C for 1 h. Formation of insoluble filaments was checked by
centrifugation of aliquots (30 μL, 25 μg/mL) at 20,000 × g at 22˚C for 30 min. Analysis of pro-
teins in the pellet and supernatant by SDS-PAGE revealed that desmin was 90% insoluble.
For each binding assay, the whole assembly procedure, consisting of IF protein(s) dialysis,
IF-assembly induction in the high ionic strength buffer and final dilution(s), was performed
just before use.
Fluorescence binding assays to assembled IFs. To prepare cell lysates used in our bind-
ing assays on in vitro assembled IFs, HEK 293T cells, expressing EGFP-DSP C-terminus or
EGFP, were lysed in the same buffer used to assemble K5/K14 or desmin IFs (see above), sup-
plemented with 0.1% Triton X-100 and 1/100 protease inhibitor cocktail (Sigma-Aldrich). Cell
lysates were centrifuged at 20,000 × g at 4˚C for 30 min and the supernatants saved. Both the
protein concentration and fluorescence were measured in these soluble fractions. Soluble
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extracts from non-transfected cells, diluted at the same protein concentration as that of fluo-
rescent soluble extracts with the appropriate IF-assembly buffer, were used to prepare serial
dilutions of fluorescent cell extracts so that the final protein concentration was the same in all
fluorescent samples. Serially diluted cell extracts containing EGFP-DSP C-terminus or EGFP,
40 μL each, were mixed with 10 μL of in vitro assembled IFs, 125 μg/mL (25 μg/mL final), incu-
bated 15 min either at 4˚C with K5/K14 IFs or at 22˚C for desmin under agitation (300 rota-
tion per minute) and centrifuged at 20,000 × g at 4˚C or 22˚C, respectively, for 30 min.
Fluorescence in the supernatant, 5 μL sample to 95 μL PBS, 0.1% BSA in 96-well plate with
round bottom in triplicate, was measured with Tecan Spark 10M (Tecan). EGFP-DSP C-ter-
minus and EGFP concentrations were determined using a fluorescence standard curve
obtained with pure recombinant EGFP-H6 [30]. Binding curves were fitted with GraphPad
Prism 7, non-linear regression, one site, specific binding with Hill slope. SDS-PAGE analysis
of the insoluble fractions of the binding assays, previously washed with 40 μL assembly buffer,
indicated that the insolubility of K5/K14 IFs or desmin IFs was not affected by the addition of
the soluble fraction of HEK 293T cells.
To measure the percentage of active IF-binding EGFP-DSP C-terminus among the soluble
extracts of transfected HEK 293T cells, the concentration of EGFP-DSP C-terminus was kept
constant at 25 nM whereas that of in vitro assembled K5/K14 or desmin IFs was varied from 0
to 250 μg/mL in a final volume of 50 μL. At the highest concentration of IFs, insoluble fluo-
rescence was 90% of the fitted Bmax value. Remaining soluble fluorescence (% of total fluo-
rescence) was considered as inactive EGFP-DSP C-terminus [44].
Results
The C-terminus of desmoplakin interacts with the coil 1 of epidermal Ks,
desmin, and vimentin
Previous studies, using Y3H assays and overlay assays, showed that the tail and C-terminus of
desmoplakin preferentially bound to heterodimeric Ks K1/K10, K5/K14, and K8/K18 when
compared with monomeric Ks [8, 30]. Similar results were obtained in quantitative fluores-
cence-based overlay assays with the C-terminus of desmoplakin tagged at the N-terminus with
EGFP (EGFP-DSP C-terminus) (S3 Fig). Together, these results indicate that the quaternary
structure associated with dimerization/tetramerization of Ks is a key factor for their associa-
tion with the tail and C-terminus of desmoplakin.
To dissect sequences within IF proteins essential for their binding to desmoplakin in Y3H
assays, we generated a series of deletion constructs encompassing various portions of K5 and
K14. First, we showed that truncated K5 and K14 proteins were still able to interact with each
other (heterodimerization) in Y2H assays like the full-length proteins (S2 Table). Next, we
tested whether truncated K5 and K14 could interact with the C-terminus of desmoplakin in
Y3H assays. Our analyses revealed that the co-expression of K5 and K14 proteins containing
their coil 1 was indispensable for interaction with the C-terminus of desmoplakin (Fig 1). Our
findings were validated in follow-up FluoBACE assays. EGFP-DSP C-terminus bound to the
pair consisting of H6-tagged coils 1 of K5 and K14. However, it did not interact with the pair
made of full-length K5 and H6-tagged coil 2 to tail (C2-T) of K14 (Fig 2A and 2B). Identical
results were obtained when deletion mutants of K1 and K10, corresponding to those of K5 and
K14, were tested in overlay assays (Fig 2C and 2D). Hence, our results strongly suggest that the
heterodimeric coil 1 of epidermal Ks is a major binding site for the C-terminal region of des-
moplakin. Nevertheless, since in our assays the binding of the C-terminus of desmoplakin to
K-coils 1 was systematically weaker than to the full-length proteins (Fig 2B and 2D), we cannot
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exclude the possibility that there are additional binding sites on Ks contributing to their inter-
action with desmoplakin.
Based on our previous study that shows that the C-terminus of desmoplakin interacts in
vitro with tail-less type III IF proteins [9], we decided to also characterize the IF-binding site(s)
on vimentin and desmin by the FluoBACE method. These IF proteins were expressed in E. coli
and transferred by electrophoresis to a nitrocellulose membrane after size-fractionation on
denaturing polyacrylamide gels (SDS-PAGE). EGFP-DSP C-terminus consistently bound to
full-length desmin and vimentin, their rod and coil 1 domains but not to their coil 2 domain
(Fig 3A). Interestingly, it was previously reported that both the vimentin coil 1 and 2 homodi-
merize in vitro to similar extents [45]. Despite the absence of binding of the C-terminus of des-
moplakin to the coil 2 of vimentin or desmin and to SUMO, analysis of results with one-way
ANOVA-Tukey test indicates that only the binding of the C-terminus of desmoplakin to full-
length vimentin is significantly different from all the other proteins (Fig 3B). In contrast, a t-
test between the coils 1 and 2 of vimentin or desmin gives P values 0.01. These results imply
that the coil 1 domain of both dimeric types I/II as well as of III IFs contains a conserved motif
that serves as a major binding site for the C-terminus of desmoplakin.
Next, we analyzed the impact of selected amino acid substitutions associated with epider-
molysis bullosa simplex (EBS) located within or close to the coil 1 of either K5 or K14 on the
Fig 1. The coil 1 of K5/K14 is essential for their interaction with the C-terminus of desmoplakin in Y3H assays.
Summary of Y2/3H results obtained with the indicated constructs. Numbers in each protein show amino acid order. K
domains are labeled; the coils are drawn as boxes. + or − means growth or no growth, respectively, on selection
medium without histidine (His) or adenine (Ade).
https://doi.org/10.1371/journal.pone.0205038.g001
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ability of the heterodimeric proteins to interact with the C-terminus of desmoplakin in Y3H
assays. None of the tested EBS variants, K5 p.(Glu168Asp), p.(Glu168Gln), p.(Asn176Ser), p.
(Asn177Ser), p.(Leu311Arg) and K14 p.(Arg125His), p.(Ile176Met), p.(Val270Met), p.
(Leu284Pro), prevented the interaction with the C-terminus of desmoplakin when associated
with its wild-type K partner (S3 Table). Consequently, impaired binding of these EBS K
mutants to desmoplakin does not seem be to be a major factor for their pathogenicity.
The C-terminus of desmoplakin has high affinity binding sites for K5/K14
and desmin IFs
Several studies have provided experimental evidence that the C-terminus of desmoplakin con-
tains different domains that synergistically contribute to robust binding to IFs and confer
mechanical resilience to cells [7–9, 29, 46, 47]. Nevertheless, the apparent affinity of the C-
Fig 2. The coil 1 of K5/K14 and K1/K10 contains the major binding site(s) for the C-terminus of desmoplakin in overlay assays.
(A) Nitrocellulose membranes, spotted as indicated with bovine serum albumin (BSA, control) and individual or mixed (/) K5 and
K14, either full-length proteins or the fragments coil 1 (C1) and coil 2 to tail (C2-T) (3 pmol/spot), were stained with amido black or
overlaid with soluble extracts of HEK 293T cells expressing either EGFP-DSP C-terminus (64 ± 29 nM, total concentration) or EGFP
( 70 nM) and scanned for fluorescence. (B) Quantified fluorescence signals are relative to the normalized results obtained with the
mixture (/) of full-length K5/K14. K5 + K14 and K5-C1 + K14-C1 correspond to the sum of fluorescence signals obtained with the
individual proteins (not mixed). Mean ± SD, n = 3; ANOVA-Tukey test;  and , residual P< 0.01 and< 0.0001, respectively.
(C) and (D) as for (A) and (B) with K1 and K10.
https://doi.org/10.1371/journal.pone.0205038.g002
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Fig 3. The C-terminus of desmoplakin binds to the coil 1 of desmin and vimentin. (A) Purified vimentin, desmin and SUMO (negative control)
(4 μg/lane), or whole extracts from E. coli expressing full-length vimentin or desmin, the rod, coil 1 and coil 2 of these proteins or no exogenous
protein (none), as indicated, were size-fractionated on 15% SDS-PAGE and transferred to WB membranes that were stained with Ponceau-S and
overlaid with soluble extracts from HEK 293T cells expressing EGFP-DSP C-terminus or EGFP (both at 67 ± 17 nM, total concentration). M,
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terminus of desmoplakin for IFs has not been determined. To this end, we used our FluoBACE
assay on K5/K14 and desmin IFs assembled in vitro [42, 43]. First, we measured the fraction of
active EGFP-DSP C-terminus in the soluble fraction of HEK 293T cells by keeping the concen-
tration of EGFP-DSP C-terminus constant and increasing the amount of IFs (S4 Fig). About
50% (47 ± 12%, ± SD, n = 7) of the total fluorescence was bound to IFs formed either by K5/
K14 or desmin. It is possible that improper folding or inhibitory posttranslational modifica-
tions account for the inability of the remaining expressed portion of EGFP-DSP C-terminus to
interact with IFs. Next, we varied the concentration of EGFP-DSP C-terminus present in solu-
ble HEK 293T cell extracts and kept that of K5/K14 or desmin IFs constant (25 μg/mL).
Despite the limitations of this approach, due to the maximal available concentration of active
protein ( 30 nM), we found an apparent Kd of 10 ± 2 nM for K5/K14 IFs and 18 ± 3 nM for
desmin IFs with a positive cooperativity (Hill coefficient, h) of 2.4 ± 0.6 or 2.3 ± 0.2
(mean ± SD, n = 3), respectively (Fig 4). The control EGFP did not bind to insoluble IFs.
Unfortunately, it is technically challenging to produce intact soluble EGFP-DSP C-terminus in
E. coli to test higher concentrations [30]. Since IF proteins require specific assembly conditions
in high ionic strength buffers, the apparent Kd values obtained with the C-terminus of desmo-
plakin for K5/K14 and desmin cannot be directly compared.
markers. (B) Quantified fluorescence signals are relative to the normalized results obtained with full-length vimentin, mean ± SD, n4;
ANOVA-Tukey test;  and , residual P< 0.001 and< 0.0001, respectively.
https://doi.org/10.1371/journal.pone.0205038.g003
Fig 4. Binding of the C-terminus of desmoplakin to K5/K14 and desmin IFs under equilibrium condition.
Variable concentrations of active EGFP-DSP C-terminus (blue, dots) in soluble HEK 293T cell extracts were mixed
with a constant concentration of in vitro assembled IFs (25 μg/mL). Binding of the control EGFP (red, inverted
triangles) was measured at the highest concentration of total (active + inactive) EGFP-DSP C-terminus. Representative
binding curves from three independent experiments are shown (RFU, relative fluorescence unit).
https://doi.org/10.1371/journal.pone.0205038.g004
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Discussion
In this study, we describe the binding properties of desmoplakin to epidermal Ks and type III
IF proteins desmin and vimentin using complementary biochemical binding assays. Our data
provide for the first time evidence that the coil 1 of heteromeric K5/K14, K1/K10 and homo-
meric desmin and vimentin IF proteins contain recognition sites that bind desmoplakin. Our
finding contradicts the reported specificity of desmoplakin and its tail for the unique head
domain of most type II Ks except K8 [12, 29]. Specifically, Kouklis et al. [12] reported that a
region encompassing the KSIS motif within the head domain of K1 and K5 was crucial for the
interaction of desmoplakin with epidermal Ks. Similarly, Meng et al. [29] found that the head
domain of K1 was essential for its interaction with desmoplakin by Y2H assays and by peptide
competition in in vitro binding experiments. Furthermore, no association of the tail of desmo-
plakin with vimentin could be demonstrated in immune overlay assays [11]. The discrepancies
between these results and ours may be due to the use in overlay assays of improperly folded
desmoplakin proteins that were purified in denaturing conditions [12, 29]. In contrast to the
latter studies, here and in our previous investigations we used native recombinant desmopla-
kin proteins [8, 9].
Depending on the assay, Y2H or overlay with in vitro translated proteins, we found that the
tail of desmin was either critical or dispensable, respectively, for its interaction with desmopla-
kin [14]. It is worth noting, however, that Y2H system is a screening strategy that is prone to
false positive and negative results that must be verified with additional tests [47]. Here, we
used a second binding assay that confirms that the tails of desmin and vimentin are dispens-
able for their interaction with the C-terminus of desmoplakin [9]. This finding is supported by
the fact that the tails of IF proteins significantly differ from each other and are thus unlikely to
provide a common binding site that accounts for the broad specificity of desmoplakin for IFs.
The same remark applies to the head domains of IF proteins.
Our binding results, describing desmoplakin and IFs association, agree well with those
reported for plectin, another plakin protein with a similar C-terminal structure (S1 Fig). The
C-terminus of plectin predominantly binds to the coil 1 domain of K5/K14, desmin, and
vimentin [11, 30, 33]. Furthermore, the unique PRD of envoplakin interacts with the mono-
meric coil 1 of vimentin [48]. Based on these results, it is tempting to conclude that plakins
bind to a similar set of sequences within the conserved dimeric/tetrameric coil 1 region of Ks
and type III IF proteins (S5 Fig). The interaction of the PRD B of envoplakin with the mono-
meric coil 1 of vimentin seems to depend on ionic interactions between basic amino acids in
the former (Lys1901 and Arg1914) and acidic amino acids in the coil 1A of the latter (Asp112
or Asp119) [48]. However, salt concentrations did not affect the interaction of desmoplakin
PRDs with vimentin [46]. Therefore, the exact contribution of ionic interactions between the
C-terminus of desmoplakin and IF proteins remains to be determined in future studies.
One of the most common causes for EBS are heterozygous missense variants in the genes
encoding K5 and K14, KRT5 and KRT14 respectively. These mutations, which are typically
found in conserved helix boundary motifs of the rod domain, are thought to be pathogenic by
affecting the assembly of K5/K14 in keratinocytes, although additional mechanisms could be
involved [24, 49, 50]. We therefore tested the hypothesis that defective linkage of IFs to cell
membrane sites could contribute to the cytoskeletal disorganization observed in EBS keratino-
cytes. However, despite the crucial binding of desmoplakin to the coil 1 of Ks, none of the ana-
lyzed EBS-associated mutations within or close to the coil 1 of K5 or K14 prevented the
interaction with desmoplakin in Y3H assay. Nevertheless, because of the mainly qualitative
properties of the Y2/3H system (growth/no growth), it cannot be excluded that some of these
mutations weakened the interaction with desmoplakin but not enough to abolish it, even on
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the medium without adenine, which is more stringent than the medium without
histidine. Recently, we reported that several amino acid substitutions in the PRD B and C of
the C-terminus of desmoplakin reduce its interaction with various Ks and type III IF proteins
[51, 52]. This indicates a common binding mode of the C-terminus of desmoplakin to differ-
ent IFs.
The interaction of desmoplakin with the coil 1 of IF proteins provides a logical explanation
for the broad specificity of most plakins for various IF proteins. However, it should be empha-
sized that the C-terminus of desmoplakin bound more strongly to full-length IF proteins than
to their coil 1. This observation may be due to either variable accessibility to the binding sites
on smaller proteins immobilized on a nitrocellulose membrane or to the different assembly
stage of immobilized full-length proteins versus coil 1 dimers. It cannot be excluded either that
domains other than the coil 1 within IF proteins synergistically contribute to the binding of
IFs to desmoplakin.
Based on the obtained FluoBACE binding curves the apparent Kd of the C-terminus of des-
moplakin for IFs is in the nM range, which is comparable to that of plectin (S4 Table). This
high binding affinity probably constitutes a requisite for the robust anchoring of IFs to mem-
brane sites to impart mechanical resilience in vivo. Actually, the affinity of the tail of desmopla-
kin for IFs could be even higher than that of the C-terminus because there are reports
indicating that the PRD A is also involved in the binding of desmoplakin to IFs [46, 53]. How-
ever, the lower expression level of the tail compared to the C-terminus of desmoplakin in HEK
293T cells and our inability to produce intact soluble tail of desmoplakin in E. coli [30] have
prevented us to measure the affinity for IFs of the entire tail of desmoplakin, comprising the
PRD A domain.
Although the association between IFs and the C-terminus of desmoplakin is strong, there
are regulatory mechanisms that temporarily modulate this interaction. In fact, posttransla-
tional modifications, such as phosphorylation events, control not only the assembly stage of
IFs but also the interaction between desmoplakin and IFs in processes such as cell migration,
cell mitosis and stress responses [28, 54]. Both desmoplakin and plectin contain two clusters of
phospho-sites flanking their last PRD (S1 Fig). However, while the C-terminal cluster of phos-
pho-sites has been partially characterized [15, 16], nothing is known about the role of the phos-
pho-sites located before the last PRD.
In conclusion, the interaction of desmoplakin with Ks and type III IF proteins mainly
depends on the conserved coil 1 domain of IF proteins, an observation explaining the broad
specificity of desmoplakin for various IFs.
Supporting information
S1 Fig. Domain organization of the tail and C-terminus of desmoplakin; comparison with
the C-termini of plectin and BPAG1e; sequence alignment of two clusters of phosphory-
lated sites located in the C-termini of desmoplakin and plectin. A) Amino acid labeling of
desmoplakin (DSP), plectin (PLEC) and BPAG1e corresponds to GenBank protein sequences
NP_004406, NP_958782 and NP_001714, respectively; carboxyl extremity, E. B) P-cluster 1
precedes the last PRD in both proteins, PRD 3/C in DSP and PRD 6/C in PLEC. The first
amino acid of these PRDs is in blue. Phosphorylated residues are in red, the underlined resi-
dues were found phosphorylated  10 × for plectin and 5 × for DSP (www.phosphosite.
org). C) P-cluster 2 is located in the COOH-extremity of both proteins just after the last PRD
C. The last amino acid of the PRD C is in blue. Methylated Arg are in green. Identified protein
kinases and phosphatase are indicated. GSK3β, glycogen synthase kinase 3β; MNK2, mitogen-
activated protein kinase-interacting serine/threonine protein kinase 2; PKA, cyclic AMP-
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dependent protein kinase; PP2A, protein phosphatase 2A.
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S2 Fig. SDS-PAGE analysis of purified recombinant Ks. The indicated proteins (1 μg/lane)
were size fractionated on 12% SDS-PAGE that was stained with Coomassie brilliant blue. M,
markers.
(PDF)
S3 Fig. The C-terminus of desmoplakin binds more strongly to heteromeric than mono-
meric Ks in fluorescence overlay assays. A) Nitrocellulose membranes, spotted with BSA
(control) and individual or mixed (/) cytokeratins (3 pmol/spot) were stained with amido
black or overlaid with soluble extracts of HEK 293T cells expressing either EGFP-DSP C-ter-
minus (55 ± 21 nM, total concentration) or EGFP ( 60 nM) and scanned for fluorescence. B)
Quantified fluorescence signals are relative to the normalized results obtained with each mix-
ture (/) of keratins (K1/K10, K5/K14 and K8/K18). K1 + K10, K5 + K14 and K8 + K18 corre-
spond to the sum of the fluorescence signals obtained with the individual proteins (not
mixed). Mean ± SD, n3; ANOVA-Tukey test;  and , residual P< 0.01 and < 0.0001,
respectively.
(PDF)
S4 Fig. Saturation binding curves of K5/K14 and desmin IFs to the C-terminus of desmo-
plakin under equilibrium conditions. Variable concentrations of K5/K14 IFs or vimentin
IFs, preassembled in vitro, were mixed with a constant concentration (22 nM) of EGFP-DSP
C-terminus or EGFP in the soluble extracts of HEK 293T cells. Representative binding curves
from 3 independent experiments are shown.
(PDF)
S5 Fig. Sequence alignment of the coil 1 of Ks, desmin and vimentin. The MAFFT algorithm
was used; ,:, and. denote identity, conserved and semi-conserved amino acid substitutions,
respectively. The position in the protein sequence of the first amino acid in each row is indi-
cated.
(PDF)
S1 Table. Tested recombinant IF proteins.
(PDF)
S2 Table. Y2H assay results with some K5 and K14 constructs used to map the interacting
domain(s) with the C-terminus of desmoplakin in Y3H assays.
(PDF)
S3 Table. KRT5 and KRT14 variants associated with EBS and tested in Y3H assays with
their wild-type partner and the C-terminus of desmoplakin.
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S4 Table. Apparent Kd of plakins for IF proteins reported in the literature.
(PDF)
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